SOX2 and central nervous system cancer: To characterize the impact of SRR2 enhancer in SOX2 expression on glioma cells, we performed ChIP assays in U87MG and T98G parental and U87MG oncosphere populations, studying the presence or absence of p27KIP1 in this region.